The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Randomized, open-label, phase 2/3 study of daratumumab (DARA) with or without JNJ-63723283, an anti-PD-1 monoclonal antibody, in relapsed/refractory multiple myeloma (RRMM).
 
Jan Van Droogenbroeck
Consulting or Advisory Role - Celgene; Novartis
 
Philip Vlummens
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Celgene; Takeda
 
Noa Lavi
No Relationships to Disclose
 
Ka Lung Wu
Consulting or Advisory Role - Amgen; Janssen; Takeda
 
Jiayu Fu
Employment - Janssen
 
Huaibao Feng
Employment - Janssen
 
Robin L. Carson
Employment - Janssen
 
Wendy Crist
Employment - Janssen
 
Jordan Schecter
No Relationships to Disclose
 
Yael Cohen
Employment - UBL; VBL Therapeutics
Leadership - UBL; VBL Therapeutics
Consulting or Advisory Role - Amgen; BMS Brazil; Janssen; Takeda
Speakers' Bureau - Amgen
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Janssen; NeoPharm